Search

Eight crossbred steers (BW 719.0 ± 65.0 kg) with ruminal and duodenal cannulae were used to examine the effect of trace mineral (TM) source on digestibility; ruminal and duodenal solubility of Cu, Zn, and Mn; and in vitro release of Cu, Zn, and Mn from the solid fraction of ruminal digesta. Experiment 1 determined the effect of TM source on DM and NDF digestibility in steers fed a corn silage and steam-flaked corn-based diet. Treatments consisted of 10 mg Cu, 20 mg Mn, and 30 mg Zn/kg DM from either sulfate TM (STM) or hydroxy TM (HTM) sources. Following a 14-d adaptation period, total fecal output was collected for 5 d. Dry matter digestibility was not affected by treatment, but NDF digestibility tended (P < 0.09) to be greater in HTM vs. STM supplemented steers. In Exp. 2, steers were fed a diet without supplemental Cu, Zn, or Mn for 19 d. Steers were then administrated a pulse dose of STM or HTM (2× the National Research Council requirements for Cu, Mn, and Zn) via the rumen fistula. Ruminal and duodenal samples were obtained at 2-h intervals starting at −4 and ending at 24 h relative to dosing. Ruminal soluble Cu and Zn concentrations were affected by treatment, time, and treatment × time. Soluble concentrations and percent soluble Cu and Zn in ruminal digesta increased (P < 0.05) above 0-h values for 10 h following dosing with STM, but not HTM. Concentrations of Cu and Zn in ruminal solid digesta were also affected by treatment, time, and treatment × time. Steers dosed with STM had greater (P < 0.05) solid digesta Cu concentrations at 2 and 4 h but lesser (P < 0.05) concentrations from 6 to 20 h post-dosing than those receiving HTM. Ruminal solid digesta Zn concentrations were greater (P < 0.05) in HTM vs. STM-dosed steers from 6 through 24 h post-dosing. Distribution of Mn in ruminal digesta was affected by TM source, but to a lesser extent than Zn and Cu. Duodenal soluble TM concentrations were variable and not affected by treatment. Binding strength of TM to ruminal solid digesta was estimated at 0, 6, and 12 h post-dosing using dialysis against chelating agents. The percentage of Cu and Zn released from ruminal solid digesta by dialysis against Tris–EDTA was greater (P < 0.05) at 12 h post-dosing from steers receiving HTM vs. STM. Results indicate that Cu and Zn from HTM have low solubility in the rumen and appear to be less tightly bound to ruminal solid digesta than Cu and Zn from STM. [ABSTRACT FROM AUTHOR]

Four hundred crossbred steers were used in a randomized complete block design to investigate the effects of supplemental Zn source and concentration, and dietary Cr on performance and carcass characteristics of feedlot steers fed a steam-flaked corn-based finishing diet. Steers were blocked by initial BW within cattle source (3 sources) and randomly assigned within block to 1 of 5 treatments. Before the initiation of the experiment, trace mineral supplement sources were analyzed for Zn and Cr. Zinc and Cr concentrations of the Zn sources were used to balance all dietary treatments to obtain correct Zn and Cr experimental doses. Treatments were the addition of: 1) 90 mg Zn/kg DM from ZnSO4 and 0.25 mg Cr/kg DM from Cr propionate (90ZS+Cr); 2) 30 mg Zn/kg DM from Zn hydroxychloride and 0.25 mg Cr/kg DM from Cr propionate (30ZH+Cr); 3) 90 mg Zn/kg DM from Zn hydroxychloride and 0.25 mg Cr/kg DM from Cr propionate (90ZH+Cr); 4) 60 mg Zn/kg DM from ZnSO4 and 30 mg Zn/kg DM from Zn methionine (90ZSM); and 5) 90 mg Zn/kg DM from Zn hydroxychloride (90ZH). Steers were individually weighed on d-2 and on 2 consecutive days at the end of the experiment. Initial liver biopsies were obtained from all steers at processing. Equal numbers of pen replicates per treatment were slaughtered at a commercial abattoir on day 162, 176, and 211; individual carcass data and final liver samples were collected. Total finishing dietary Zn and Cr concentrations were 118.4, 58.2, 114.2, 123.0, and 108.2 mg Zn/kg DM and 0.740, 0.668, 0.763, 0.767, and 0.461 mg Cr/kg DM, for treatments 1 to 5, respectively. Data were analyzed statistically using preplanned single degree of freedom contrasts. Steers receiving 90ZH+Cr had greater final BW (P < 0.04) and ADG (P < 0.03) when compared with steers receiving 90ZH. Additionally, hot carcass weight was 8.5 kg greater (P < 0.03) for 90ZH+Cr compared with 90ZH supplemented steers. Steers receiving 90ZH+Cr had greater longissimus muscle area when compared with steers receiving 90ZSM. Dry matter intake, G:F, morbidity and mortality, and all other carcass measurements were similar across treatments. These data indicate that under the conditions of this experiment, Zn source and concentration had no impact on live performance, liver Zn and Cu concentrations, and carcass characteristics. Supplemental Cr in diets containing 90 mg of supplemental Zn/kg DM from ZH improved final BW, ADG, and hot carcass weights. [ABSTRACT FROM AUTHOR]

Abstract: Gene delivery by intravenous injection of cationic liposome–DNA complexes (LDC) can generate efficient transgene expression in the lungs and other organs, but the duration of expression is typically short. Previous studies have suggested a major role for interferon-γ (IFN-γ) and TNF in this process. However, plasmid DNA is also capable of eliciting production of type I IFNs. Therefore, we assessed the ability of LDC to elicit production of type I IFNs in vivo and assessed the effects of type I IFNs on suppression of transgene expression following in vivo gene delivery with LDC. Injection of LDC was found to induce production of high levels of both IFN-α and IFN-β in vivo. Moreover, the levels of transgene expression following in vivo gene delivery were markedly increased in mice lacking functional type I IFN receptor genes, compared to wild-type mice or mice lacking IFN-γ or TNF receptors. Addition of recombinant IFN-α and IFN-β inhibited transgene expression by in vitro-transfected endothelial cells, and incubation of macrophages with LDC in vitro triggered production of both IFN-α and IFN-β. Therefore, type I IFNs appear to play a key role in suppressing transgene expression in vivo following systemic nonviral gene delivery using LDC. [Copyright &y& Elsevier]

The purpose of this study was to evaluate the effect of successful treatment for Bartonella spp, Mycoplasma hemofelis or Candidatus Mycoplasma haemominutum infection of cats on results of diagnostic test results commonly available to veterinary practitioners through commercial diagnostic laboratories. Evidence of infection or exposure to Bartonella spp, M hemofelis or Candidatus M. haemominutum was detected in 15 cats with fever. Doxycycline (50 mg) or orbifloxacin (22.7 mg) were administered empirically by mouth for 28 days to 12 cats with laboratory evidence of Bartonella spp infection alone and three cats with laboratory evidence of Bartonella spp and M. hemofelis or Candidatus M. haemominutum co-infection with the laboratory tests repeated on Day 35 and 58 (10 cats) or Day 35 alone (5 cats). While clinical illness in all 15 cats rapidly resolved, all nine cats that were PCR positive for Bartonella spp on Day 0 were still PCR positive on Day 35. Four of the six cats tested on Day 58 were still positive. Only one cat that was positive for Bartonella spp antibodies detected by ELISA on Day 0 was negative on Day 35 and Day 58. Of the 3 cats that were PCR positive for M. hemofelis or 'Candidatus M. haemominutum' on Day 0, only 1 cat (Candidatus M. haemominutum' was PCR positive on Day 35 or Day 58. The results of the study support the recommendation that cats with suspected clinical bartonellosis should be evaluated concurrently by PCR (or culture) and serology. There appears to be little indication for following Bartonella spp assay results within the first 30 days using the treatment protocols described herein. [ABSTRACT FROM AUTHOR]

IFN-α has been shown to induce both antiviral and antiproliferative activities in animals. This report describes the biological activity of five recently identified feline IFN-α subtypes expressed in the Chinese hamster ovary (CHO) cell line (rfeIFN-α1[CHO], rfeIFN-α2[CHO], rfeIFN-α3[CHO], rfeIFN-α5[CHO] and rfeIFN-α6[CHO]) and the feIFN-α6 subtype expressed in and purified from Pichia pastoris (rfeIFN-α6[P. pastoris]). The rfeIFN-α[CHO] subtypes were tested for antiviral activity against either Vesicular stomatitis virus (VSV) or feline calicivirus (FCV) infected feline embryonic fibroblast cell line (AH927) or Crandell feline kidney cell line (CRFK). Antiviral activity was induced against both VSV and FCV infected AH927 cells and VSV infected CRFK cells by all five of the rfeIFN-α[CHO] subtypes and rfeIFN-α6[P. pastoris]. In addition, the IFN-α inducible Mx gene (associated with antiviral activity) was upregulated in vivo 24 h following treatment with rfeIFN-α6[P. pastoris], compared to baseline levels seen prior to treatment. All of the rfeIFN-α[CHO] subtypes and rfeIFN-α6[P. pastoris] exhibited antiproliferative activity in the FeT-J cell line (an IL-2 independent feline T-cell line). Both necrosis and apoptosis were observed in rfeIFN-α6[P. pastoris]-treated FeT-J cells. The rfeIFN-α3[CHO] subtype consistently exhibited lower antiviral and antiproliferative activity compared to that observed with the other four rfeIFN-α[CHO] subtypes. In summary, this paper demonstrates that five previously described feIFN-α subtypes induce both antiviral and antiproliferative activities in vitro and are capable of upregulating the feMx gene in vivo. [Copyright &y& Elsevier]

Reliable housekeeping gene controls are critical for measuring and comparing gene expression at the transcription level by Northern blot and RT-PCR. In order to develop such controls for studying cytokine mRNA expression in dogs, DNA sequence encoding a full-length canine HPRT protein has been obtained. Numerous primer pairs derived from the canine HPRT sequence have been tested on canine genomic DNA as well as cDNA. The data from the present study suggest that there may be processed HPRT pseudogenes in dogs. Three pairs of canine HPRT primers designed and tested in the present study were able to differentiate between cDNA and genomic DNA under specific PCR conditions. These primers would be useful controls for measurement of mRNA expression by RT-PCR in the dog. [Copyright &y& Elsevier]

Eight crossbred steers (BW 719.0 ± 65.0 kg) with ruminal and duodenal cannulae were used to examine the effect of trace mineral (TM) source on digestibility; ruminal and duodenal solubility of Cu, Zn, and Mn; and in vitro release of Cu, Zn, and Mn from the solid fraction of ruminal digesta. Experiment 1 determined the effect of TM source on DM and NDF digestibility in steers fed a corn silage and steam-flaked corn-based diet. Treatments consisted of 10 mg Cu, 20 mg Mn, and 30 mg Zn/kg DM from either sulfate TM (STM) or hydroxy TM (HTM) sources. Following a 14-d adaptation period, total fecal output was collected for 5 d. Dry matter digestibility was not affected by treatment, but NDF digestibility tended (P < 0.09) to be greater in HTM vs. STM supplemented steers. In Exp. 2, steers were fed a diet without supplemental Cu, Zn, or Mn for 19 d. Steers were then administrated a pulse dose of STM or HTM (2× the National Research Council requirements for Cu, Mn, and Zn) via the rumen fistula. Ruminal and duodenal samples were obtained at 2-h intervals starting at −4 and ending at 24 h relative to dosing. Ruminal soluble Cu and Zn concentrations were affected by treatment, time, and treatment × time. Soluble concentrations and percent soluble Cu and Zn in ruminal digesta increased (P < 0.05) above 0-h values for 10 h following dosing with STM, but not HTM. Concentrations of Cu and Zn in ruminal solid digesta were also affected by treatment, time, and treatment × time. Steers dosed with STM had greater (P < 0.05) solid digesta Cu concentrations at 2 and 4 h but lesser (P < 0.05) concentrations from 6 to 20 h post-dosing than those receiving HTM. Ruminal solid digesta Zn concentrations were greater (P < 0.05) in HTM vs. STM-dosed steers from 6 through 24 h post-dosing. Distribution of Mn in ruminal digesta was affected by TM source, but to a lesser extent than Zn and Cu. Duodenal soluble TM concentrations were variable and not affected by treatment. Binding strength of TM to ruminal solid digesta was estimated at 0, 6, and 12 h post-dosing using dialysis against chelating agents. The percentage of Cu and Zn released from ruminal solid digesta by dialysis against Tris–EDTA was greater (P < 0.05) at 12 h post-dosing from steers receiving HTM vs. STM. Results indicate that Cu and Zn from HTM have low solubility in the rumen and appear to be less tightly bound to ruminal solid digesta than Cu and Zn from STM. [ABSTRACT FROM AUTHOR]